Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2026-02-18 @ 1:10 AM
Study NCT ID:
NCT01745367
Status:
TERMINATED
Last Update Posted:
2020-10-27
First Post:
2012-12-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Tivozanib in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer
Sponsor:
AVEO Pharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Triple Negative Breast Cancer | View |